Advancements in Pulmonary Embolism Management: Current Approaches and Future Directions
Abstract
Pulmonary embolism (PE) is one of the leading causes of cardiovascular mortality, with a high 30-day mortality rate. Despite clear treatment guidelines based on patient risk profiles, evidence suggests a discrepancy between clinical practice worldwide and the recommendations outlined in these guidelines. This deviation is often due to the comorbidities present in patients with PE, which complicate management decisions. As a result, alongside traditional standard-of-care treatments, novel emerging therapies are being explored to address these challenges. This review aims to provide an overview of the current epidemiology, initial assessment strategies, conventional treatment options, and emerging therapeutic approaches for PE.
Read the paper
Related studies
- A Survey on Knowledge Graphs: Representation, Acquisition, and Applications
- Toxicity of nanomaterials
- The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies
- Halogen bonding (X‐bonding): A biological perspective
- Biofilm formation at the air–liquid interface by the Pseudomonas fluorescens SBW25 wrinkly spreader requires an acetylated form of cellulose
- Opioid Activation of Toll-Like Receptor 4 Contributes to Drug Reinforcement
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.